The popularity of Sildenafil initially sparked a surge for the drug industry, but recent shifts present a complicated scenario for investors. Generic versions are eating into earnings, and continued legal battles add https://frasergdqc763590.anchor-blog.com/21583164/sildenafil-and-the-pharmaceutical-industry-a-volatile-investment